CIDRAP newsletters options
Flu levels are up sharply in some Australian states, putting pressure on healthcare systems that are also coping with ongoing COVID-19 activity and prompting more efforts to get more people vaccinated against flu.
A study from Israel published today in BMJ shows that the effectiveness of a fourth dose of Pfizer-BioNTech's mRNA COVID vaccine waned faster than a third dose in adults ages 60 and older.
The CDC says many patients have a distinctive monkeypox rash around their genitals, and UK officials report 36 new infections.
A plant closing could affect 5 essential generic drugs for which Teva had an over 15% market share.
FDA advisers will meet in a few weeks to discuss emergency use of 3 doses.
Compared with Omicron, MIS-C rate was 14 times higher amid Alpha and 13 times higher during Delta.
While COVID-19–related thyroid inflammation usually resolves shortly after the acute illness, about half of participants in a study presented today at the 24th European Congress of Endocrinology still had thyroid abnormalities a year later. The congress is being held May 21 to 24 in Milan, Italy.
The World Health Organization (WHO) last week published its strategic priorities for tackling antimicrobial resistance (AMR).
The document lays out four strategic priority areas that incorporate what the WHO says are the essential components of the AMR response at global, regional, and country levels. It also lists the key achievements and the next steps that need to be taken in those four areas.
A large study shows a 12.8% long COVID decline after the first dose and an 8.8% drop after the second.
At least 8 European countries and Canada, the US, and Australia have tallied cases.
Only 16% of people in low-income countries have received a single COVID vaccine dose.
More adults died of COVID-19 in Massachusetts in the first 8 weeks of the SARS-CoV-2 Omicron variant surge than in the entire 23-week Delta period, suggests a modeling study published today in JAMA.
A study by Centers for Disease Control and Prevention researchers found that, despite changes in infection control practices, antibiotic use, and healthcare delivery during the first year of the COVID-19 pandemic, Clostridioides difficile infection rates did not change. The findings were published yesterday in Infection Control & Hospital Epidemiology.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The recommendation passed with 11 yes votes, 1 no vote, and 1 abstention.
Allergic conditions were not elevated in preschoolers.
As cases climb in several nations, an expert notes, "We are much more susceptible to poxviruses."
Three quarters of US adult and pediatric patients with long COVID were never hospitalized for their infections, and 31% had no preexisting chronic conditions, concludes an observational Fair Health report released yesterday.
The New York City-based nonprofit analyzed its collection of private healthcare claims data from 78,252 long-COVID patients from Oct 1, 2021, to Jan 31, 2022.
Germany recently reported a swine-origin variant H1N1 (H1N1v) influenza infection, which was identified during routine surveillance, the World Health Organization (WHO) said today in a statement.
Also, an expert panel says the world isn't better prepared to face a new health threat than when COVID first arrived.
